OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons
Li-Wei Tung, Guan‐Ling Lu, Yen-Hsien Lee, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169

Endocannabinoid modulation of dopamine neurotransmission
Dan P. Covey, Yolanda Mateo, David Sulzer, et al.
Neuropharmacology (2017) Vol. 124, pp. 52-61
Open Access | Times Cited: 153

Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons
Corey Baimel, Benjamin K. Lau, Min Qiao, et al.
Cell Reports (2017) Vol. 18, Iss. 6, pp. 1346-1355
Open Access | Times Cited: 128

Orexin signaling in GABAergic lateral habenula neurons modulates aggressive behavior in male mice
Meghan E. Flanigan, Hossein Aleyasin, Long Li, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 5, pp. 638-650
Open Access | Times Cited: 114

The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111

Hedonic Eating and the “Delicious Circle”: From Lipid-Derived Mediators to Brain Dopamine and Back
Roberto Coccurello, Mauro Maccarrone
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 105

Drugs, sleep, and the addicted brain
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2019) Vol. 45, Iss. 1, pp. 3-5
Open Access | Times Cited: 102

Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
Benjamin K. Lau, Daniela Cota, Luigia Cristino, et al.
Neuropharmacology (2017) Vol. 124, pp. 38-51
Closed Access | Times Cited: 91

The role of the orexin system in stress response
Derya Sargin
Neuropharmacology (2018) Vol. 154, pp. 68-78
Closed Access | Times Cited: 90

Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms
Mitchell R. Farrell, Hannah Schoch, Stephen V. Mahler
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 87, pp. 33-47
Open Access | Times Cited: 86

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77

Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling
Stephanie C. Gantz, Bruce P. Bean
Neuron (2017) Vol. 93, Iss. 6, pp. 1375-1387.e2
Open Access | Times Cited: 57

Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56

Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus
S. Mohammad Ahmadi‐Soleimani, Hossein Azizi, Heinrich S. Gompf, et al.
Neuropharmacology (2017) Vol. 126, pp. 25-37
Open Access | Times Cited: 54

A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction
Kate Z. Peters, Erik B. Oleson, Joseph F. Cheer
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 1, pp. a039305-a039305
Open Access | Times Cited: 41

Mechanisms of endocannabinoid control of synaptic plasticity
Bryony L. Winters, Christopher W. Vaughan
Neuropharmacology (2021) Vol. 197, pp. 108736-108736
Closed Access | Times Cited: 38

The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans
Illke B. Malungo, Ayanda Ngwenya, Mads F. Bertelsen, et al.
The Journal of Comparative Neurology (2025) Vol. 533, Iss. 2
Open Access

Endocannabinoids in Body Weight Control
Henrike Horn, Béatrice Böhme, L. Dietrich, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 2, pp. 55-55
Open Access | Times Cited: 43

What does the Fos say? Using Fos-based approaches to understand the contribution of stress to substance use disorders
Jayme R. McReynolds, John P. Christianson, Jordan M. Blacktop, et al.
Neurobiology of Stress (2018) Vol. 9, pp. 271-285
Open Access | Times Cited: 39

Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair
Danlei Liu, Xuefeng Zheng, Yuqing Hui, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine
David L. Bernstein, Preeti S. Badve, Jessica R. Barson, et al.
Addiction Biology (2017) Vol. 23, Iss. 5, pp. 1032-1045
Open Access | Times Cited: 36

Page 1 - Next Page

Scroll to top